Post-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma Associated Interstitial Lung Disease (SSc-ILD) in Japan

Condition:   Lung Diseases, Interstitial Intervention:   Drug: Nintedanib Sponsor:   Boehringer Ingelheim Not yet recruiting

Source: ClinicalTrials.gov - March 27, 2020 Category: Research Source Type: clinical trials